Dopamine in Urinary Disease
- Systemic Pharmacotherapeutics of the Urinary System
- Overview of Systemic Pharmacotherapeutics of the Urinary System
- Bacterial Urinary Tract Infections
- Fungal Urinary Tract Infections
- Bacterial Prostatitis
- Diuretics
- Dopamine in Urinary Disease
- Glomerular Disease
- Diabetes Insipidus
- Controlling Urine pH
- Cystine-binding Agents in Urinary Disease
- Urinary Incontinence
- Urine Retention
Dopamine, an adrenergic neurotransmitter with specific receptors in the renal vasculature, is frequently used to combat reductions in renal blood flow that may contribute to acute renal failure. It also increases glomerular filtration and sodium excretion. Dopamine has a very short half-life and is administered as a constant-rate infusion of 2–5 mcg/kg/min. Higher dosages cause tachycardia, cardiac arrhythmias, and peripheral vasoconstriction. Animals that do not produce urine with dopamine alone may respond to a combination of dopamine and furosemide. Dopamine is given as above, and furosemide is given at 1 mg/kg/hr, by IV bolus. If no improvement occurs within 6 hr, conversion is unlikely, and infusion should be discontinued. Dialysis (hemodialysis or peritoneal dialysis) may be required to maintain these animals.
- Systemic Pharmacotherapeutics of the Urinary System
- Overview of Systemic Pharmacotherapeutics of the Urinary System
- Bacterial Urinary Tract Infections
- Fungal Urinary Tract Infections
- Bacterial Prostatitis
- Diuretics
- Dopamine in Urinary Disease
- Glomerular Disease
- Diabetes Insipidus
- Controlling Urine pH
- Cystine-binding Agents in Urinary Disease
- Urinary Incontinence
- Urine Retention
Also of Interest
Test your knowledge
Administration of which of the following systemic antibiotics is most suitable for canine otitis caused by Pseudomonas aeruginosa?